Looking to the future, Hongwei Tetes will uphold the original intention of “precise diagnosis and shape a better life”, relying on our expertise to develop first-class medical products and services, operate with integrity, repay the society, and provide a guarantee for the good life of humankind.
Continuous development ...
Passed medical device quality management system certification; applied for 10 patents.
Apply for 2 patents.
Transfer of hereditary keratitis detection technology; applied for 4 patents.
Jiangsu Macro&Micro-Test Med-Tech Co., Ltd. was established to focus on the development, production and sales of in vitro diagnostic reagents for precision medicine and POCT.
Applied for 5 patents and transferred high-throughput capture sequencing technology to Zhenao Group.
Successfully developed various genetic disease detection kits, such as WILSON syndrome, deafness, and hereditary keratitis.
Cooperated with the Institute of Theoretical Physics of the Chinese Academy of Sciences and the Chinese Center for Disease Control and Prevention to develop a new near-infrared fluorescence tomography technology platform, and applied for 6 patents.
Successfully developed various drug metabolism test kits such as clopidogrel and warfarin medication guide kits.
Transfer of intellectual property rights for tumor-targeted drug products.
Successfully developed KRAS, ALK,
ROS1, CKIT and other tumor drug guidance kits, applied for 3 patents.
Successfully developed EGFR, BRAF and other tumor drug guidance kits, and applied for 2 patents.
Beijing Hongwei Tesi Biological Technology Co., Ltd. was incorporated.
WeChat public account
Macro & Micro-Test
Jiangsu Address: No. 888 Zhujiang Road, Digang Street, Rudong County, Jiangsu Province (Building 10, Life and Health Industrial Park, High-tech Zone)
Beijing Address: West side, 3rd floor, Building 2, No. 28 Yuhua Road, Airport Science Park, Shunyi District, Beijing
Company email: email@example.com